Floatz logo

ADENOSINE

Coronary Microvascular Dysfunction

S.M. Misericordia HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Coronary Microvascular Dysfunction cohort.

Asset / SponsorPhaseRating
Tirzepatide
Tina Vilsbøll
Phase 4BB
Vericiguat
Johns Hopkins University
Phase 2B
HEPARIN
S.M. Misericordia Hospital
N/AD

Same molecule, other indications

ADENOSINE is also rated in:

PainDormant
B
Indicative ·
57 / 100
View asset →
liver and intrahepatic bile duct neoplasmDormant
CCC
Indicative ·
48 / 100
View asset →
DiabetesDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →